US › Healthcare

Utah Medical Products Inc (UTMD)

US · Healthcare · Medical Instruments & Supplies

$74.19+0.18%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$8.5M

Revenue YoY

-14.3%

Net profit

$2.7M

Profit YoY

-11.9%

EPS

$0.84

Net margin

31.5%

Key statistics

Market cap

$221.7M

P/E

21.4

Forward P/E

13.0

P/B

1.83

Book value

$37.80

EPS (TTM)

$3.25

Dividend yield

1.77%

52-week high

$75.75

52-week low

$52.87

50-day MA

$70.49

200-day MA

$64.98

Beta

0.36

Shareholding

Insiders

7.18%

Institutions

76.80%

Largest institutional holders

Fund	Stake
Brandes Investment Partners & Co	14.92%
Dimensional Fund Advisors, Inc.	6.24%
BlackRock Inc	5.89%
Renaissance Technologies Corp	5.78%
Vanguard Capital Management, LLC	4.35%
Geode Capital Management, LLC	3.77%
Minerva Advisors LLC	2.94%
Hotchkis & Wiley Capital Management LLC	2.80%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Utah Medical Products Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.